Table of Contents
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.
Methodology and Scope
This research service focuses on the global regenerative medicine market, providing a detailed
overview of cell therapies in particular. A brief overview of gene therapy, tissue engineering, and
small molecules and biologics has also been included.
This study does not include a discussion of stem cells used for drug screening or stem cell banking,
nor does it address the companies that provide stem cell culture supplies or services.
A product and pipeline assessment is provided for marketed and investigational cell therapy-based
products in the global regenerative medicine market.
Company profiles are included for those companies that are currently or imminently marketing cell-based regenerative therapies as well as conducting clinical trials worldwide.
The information contained in this research service was derived from published sources including the following: Alliance for Regenerative Medicine; disease organization Web sites; company publications, including annual reports, Securities and Exchange Commission (SEC) filings, and press releases; United States government public sources; and published articles in scientific journals.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, ...
The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source ...
This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual ...